Current Molecular Pharmacology

SCI SCIE

国际简称：CURR MOL PHARMACOL 参考译名：当前分子药理学

主要研究方向：Pharmacology, Toxicology and Pharmaceutics-Drug Discovery 非预警期刊

《当前分子药理学》(Current Molecular Pharmacology)是一本由KEAI PUBLISHING LTD出版的以Pharmacology, Toxicology and Pharmaceutics-Drug Discovery为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本开放期刊，近三年没有被列入预警名单。该期刊享有很高的科学声誉，影响因子不断增加，发行量也同样高。

2区中科院分区
Q1 JCR分区
25 年发文量
7.2 IF影响因子
开放是否OA
34 H-index
2008 创刊年份
4 issues/year 出版周期
English 出版语言

Current Molecular Pharmacology aims to publish the latest developments in cellular and molecular pharmacology with a major emphasis on the mechanism of action of novel drugs under development, innovative pharmacological technologies, cell signaling, transduction pathway analysis, genomics, proteomics, and metabonomics applications to drug action. An additional focus will be the way in which normal biological function is illuminated by knowledge of the action of drugs at the cellular and molecular level. The journal publishes full-length/mini reviews, original research articles and thematic issues on molecular pharmacology.

Current Molecular Pharmacology is an essential journal for every scientist who is involved in drug design and discovery, target identification, target validation, preclinical and clinical development of drugs therapeutically useful in human disease.

[ 查看全部 ]

投稿咨询加急咨询

Current Molecular Pharmacology期刊信息

ISSN：1874-4672
出版语言：English
是否OA：开放
E-ISSN：1874-4702
出版地区：United Arab Emirates
是否预警：否
出版商：KEAI PUBLISHING LTD
出版周期：4 issues/year
创刊时间：2008
开源占比：0
Gold OA文章占比：58.16%
OA被引用占比：0
出版国人文章占比：0.13
出版撤稿占比：0
研究类文章占比：72.00%

Current Molecular Pharmacology CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

7.8

1.024

0.919

学科类别	分区	排名	百分位
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Pharmacology	Q1	66 / 328	80%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Drug Discovery	Q1	37 / 161	77%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Molecular Medicine	Q2	51 / 179	71%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Current Molecular Pharmacology中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
否	否	生物学	2区	BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 PHARMACOLOGY & PHARMACY 药学	3区 3区

Current Molecular Pharmacology JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：BIOCHEMISTRY & MOLECULAR BIOLOGY	SCIE	Q1	46 / 328	86.1
学科：PHARMACOLOGY & PHARMACY	SCIE	Q1	32 / 356	91.2
学科：BIOCHEMISTRY & MOLECULAR BIOLOGY	SCIE	Q1	74 / 328	77.59
学科：PHARMACOLOGY & PHARMACY	SCIE	Q1	87 / 356	75.7

Current Molecular Pharmacology历年数据统计

影响因子

中科院分区

Current Molecular Pharmacology中国学者发文选摘

1、PVT1&EIF4A1 promote metastasis through regulating Notch-1 signaling pathway via STC-1 in gastric cance
Author: Cao, Dongdong; Yang, Rui; Zhang, Lei; Zhou, Xuan; Zhong, Min; Pan, Zemin; Zhou, Naiming; Li, Fangling; Li, Dongmei

Journal: CURRENT MOLECULAR PHARMACOLOGY. 2026; Vol. 19, Issue 1, pp. 74-84. DOI: 10.1016/j.cmp.2026.02.003
2、Targeting fPRDM16 to restore collagen phagocytosis: A mechanism to counteract the persistent fibrosis in aging lung
Author: Peng, Jun; Zhang, Yue; Huang, Wenhui; Wang, Wei; Zeng, Wenyi; Li, Wenhan; Xiao, Linjie; Meng, Ying

Journal: CURRENT MOLECULAR PHARMACOLOGY. 2026; Vol. 19, Issue 1, pp. 61-73. DOI: 10.1016/j.cmp.2026.02.002
3、Gramine suppresses triple-negative breast cancer by inducing ferroptosis via CUL3-mediated ubiquitination of MTD
Author: Zhou, Shangjun; Zhu, Xudong; Xu, Zhijie; Yi, Qiaoli; Wang, Jiayu; Wang, Xia; Zhang, Kejing; Yu, Keda; Yan, Yuanliang

Journal: CURRENT MOLECULAR PHARMACOLOGY. 2026; Vol. 19, Issue 1, pp. 14-26. DOI: 10.1016/j.cmp.2026.03.001
4、The mechanism of lactylation modification in the progression and drug resistance of lung cancer: A revie
Author: Yi, Jiaoyu; Tao, Bo; Chen, Hao; Horita, Nobuyuki; Xu, Yong

Journal: CURRENT MOLECULAR PHARMACOLOGY. 2026; Vol. 19, Issue 1, pp. 27-40. DOI: 10.1016/j.cmp.2026.03.004
5、IGFBP1 is a potential monitoring biomarker of disease activity in elderly patients with inflammatory bowel diseas
Author: Yang, Shuting; Jiang, Tingwang; Shi, Zhiliang; Zhou, Fang; Yu, Hongshuang; Huang, Jiefang; Li, Xuefeng; Guo, Jian; Zhao, Hongmei; Zhang, Qi; Wang, Bei; Zhou, Jieru; Zhang, Yanyun; Zhou, Guoqiang

Journal: CURRENT MOLECULAR PHARMACOLOGY. 2026; Vol. 19, Issue 1, pp. 1-13. DOI: 10.1016/j.cmp.2026.02.001
6、Stimulation of Soluble Guanylyl Cyclase (sGC) by Cinaciguat Attenuates Sepsis-induced Cardiac Injur
Author: Li, Wanqian; Zheng, Cheng; Zhang, Xijiang; Wang, Binhui; Shen, Enjian; Wang, Lingjun; Chen, Guang; Lin, Ronghai

Journal: CURRENT MOLECULAR PHARMACOLOGY. 2025; Vol. 17, Issue , pp. -. DOI: 10.2174/0118761429387280250506114040
7、Regulatory Mechanisms of STAT3 in GBM and its Impact on TMZ Resistanc
Author: Lv, Guangyao; Li, Xueying; Deng, Hongtu; Zhang, Jianqiao; Gao, Xinfu

Journal: CURRENT MOLECULAR PHARMACOLOGY. 2025; Vol. 17, Issue , pp. -. DOI: 10.2174/0118761429386400250415053351
8、Network Pharmacology and Bioinformatics of Flavonoids from Scutellaria baicalensis stems: Mitigating Aβ-Induced Cognitive Impairment in Rats via the MEK-ERK-CREB Pathwa
Author: Chen, Yan; Ma, Shuai; Huo, Jing; Ding, Shengkai; Liu, Qianqian; Li, Chen; Yao, Yinhui; Shang, Yazhen

Journal: CURRENT MOLECULAR PHARMACOLOGY. 2025; Vol. 17, Issue , pp. -. DOI: 10.2174/0118761429381010250512060455